Insights
The Bright Side
At Polaris, we light up the media with good news and share inspiring stories. Gaze upon these spotlights:
Strengthening Our Scientific Team: Meet Nikolaos Daskalakis
Working with world-class scientists propels us, and every now and then, we can share a glimpse into their lives and the work they’re doing! Here's a brief Q&A with Dr. Nikolaos Daskalakis; we're thrilled to have his energy and expertise as our consulting Chief...
Milestones of 2024
We're grateful for a productive year and look forward to more partnerships and growth in 2025! At Polaris Genomics, our team is dedicated to advancing how neuropsychiatric conditions are assessed, diagnosed, and treated by linking mental health with its underlying...
Work With Us
Let’s blaze a brighter future for mental health care togetherWe're glad to connect with you. Now, let's continue to build a partnership! At Polaris Genomics, our team is dedicated to advancing how neuropsychiatric conditions are assessed, diagnosed, and treated by...
Meet Zalak Shah, Bioinformatics Scientist
We're thrilled to work with world-class scientists, and every now and then, we can share a glimpse into their lives, and the work they're doing! Here's a brief Q&A with Zalak Shah, Bioinformatics Scientist at Polaris Genomics! What are you working on right now...
The RNA Revolution: How Polaris Genomics is Tapping Into Biology for Mental Health Discovery
A must-read for scientific forward thinkers and health advocates from all walks, this article by Nobel laureate Dr. Thomas Cech discusses the growing importance of RNA in the field of biology1. This is particularly relevant for biotech companies like Polaris...
‘Pushing Boundaries,’ Polaris Genomics Receives $100,000 IGNITE Grant
Thanks to Prince William Economic Development, Polaris Genomics is honored to be one of three businesses to receive $100,000 from the IGNITE Startup Grant program. "We are thrilled to welcome new faces —and recognize the achievements of those businesses who...
iHeartRadio Features Polaris Genomics’ PTS-ID Trial
🔈 Volume Up! 🔈 We're featured this week on iHeartRadio's Moco Minute! Thanks to the Montgomery County Economic Development Corporation, PTS-ID news hits the "air waves" as trial volunteer recruitment continues. Polaris Genomics · As featured on MoCo Minute DC101...
Inside Polaris Genomics: Cracking the Code of Mental Illness with AI
At Polaris Genomics, we're on a mission to bring clarity and objectivity to mental health diagnosis. We leverage the power of genomics to understand the biological underpinnings of conditions like PTSD, aiming to transform how we diagnose and treat these invisible...
Want to Propel PTSD Research? DC-Metro Area Participants Sought for Study
Polaris Genomics has just launched its largest trial with Stella DC to further develop PTS-iD™, the first test of its kind to use genomics to unveil the physical changes underlying PTSD. “It is essential that we begin to understand what is occurring within us at...
Our Milestones & Mission Move Us Forward
At Polaris, we’re dedicated to decoding the biological fingerprints of mental health to advance the discovery and development of tools and diagnostics for a range of conditions, including PTSD, depression, anxiety, ADHD, TBI, and substance use disorder. While we...
How Polaris Genomics is Leveraging the Health Equity Assessment Tool to Enable a More Equitable Innovation Process
As featured in the Johnson & Johnson Innovation blog. Learn more...
Polaris Genomics is Featured in Founder Institute’s “Fastest Growing Companies of 2023” List
Polaris Genomics is featured in Founder Institute's "Fastest Growing Companies of 2023" list. It's an honor for the entire Polaris Genomics team and a testament to the hard work and dedication we've put into developing our genomics-informed biotech and AI tools to...